SCHEMBL15535149

SCHEMBL15535149

[CH2]CCCN1CCC(C)C1

nearest known ligand 0.42

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 6/20 0.41
CARM1 Q86X55 1/20 0.39
PRMT6 Q96LA8 1/20 0.39
PRMT1 Q99873 1/20 0.39
PRMT8 Q9NR22 1/20 0.39
ACHE P22303 1/20 0.39
HRH3 Q9Y5N1 7/20 0.37
KDM4E B2RXH2 1/20 0.35
RECQL P46063 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL735708 0.87
SCHEMBL2099496 0.87
SCHEMBL2099639 0.87
SCHEMBL9374563 0.87 SIGMAR1 (0.46) SIGMAR1CARM1PRMT6PRMT1PRMT8
SCHEMBL15760641 0.85 SIGMAR1 (0.49) SIGMAR1CARM1PRMT6PRMT1PRMT8
SCHEMBL10130235 0.81 GNAI3 (0.46) SIGMAR1
SCHEMBL10130223 0.81 GNAI3 (0.46) SIGMAR1
SCHEMBL76763 0.81 GNAI3 (0.46) SIGMAR1
SCHEMBL24582593 0.79 SIGMAR1 (0.41) SIGMAR1CARM1PRMT6PRMT1PRMT8
SCHEMBL20082498 0.79 KEAP1 (0.42) SIGMAR1CARM1PRMT6PRMT1PRMT8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4010433-A1 CHEMILUMINESCENT COMPOUNDS FOR MULTIPLEXING Abbott Laboratories (US) 2022-06-15 EP disclosed
EP-4010707-A1 METHODS FOR DETECTING ASSAY INTERFERENTS AND INCREASING DYNAMIC RANGE Abbott Laboratories (US) 2022-06-15 EP disclosed
WO-2021026403-A1 METHODS FOR DETECTING ASSAY INTERFERENTS AND INCREASING DYNAMIC RANGE ABBOTT LABORATORIES (US) 2021-02-11 WO disclosed
WO-2021026402-A1 CHEMILUMINESCENT COMPOUNDS FOR MULTIPLEXING ABBOTT LABORATORIES (US) 2021-02-11 WO disclosed
EP-3313846-A1 THIENOPYRROLE COMPOUNDS AND USES THEREOF AS INHIBITORS OF OPLOPHORUS-DERIVED LUCIFERASES Promega Corporation (US) 2018-05-02 EP disclosed
WO-2016210294-A1 THIENOPYRROLE COMPOUNDS AND USES THEREOF AS INHIBITORS OF OPLOPHORUS-DERIVED LUCIFERASES PROMEGA CORPORATION (US) 2016-12-29 WO disclosed
WO-2013177510-A1 NEURONAL NICOTINIC RECEPTOR AGONISTS FOR TREATING SCHIZOPHRENIA IN PATIENTS WITH VARIANTS OF COMT GENE ABBVIE INC. (US) 2013-11-28 WO disclosed
WO-2013177498-A1 AGONISTS OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR A7 SUBTYPE FOR USE IN THE TREATMENT OF COGNITIVE SYMPTOMS OF SCHIZOPHRENIA ABBVIE INC. (US) 2013-11-28 WO disclosed